ZSF1 obese rats exhibited these features, displaying progressive diastolic dysfunction (increased E/e ratio) over the 16 weeks, elevated left ventricular end-diastolic pressure (LVEDP), increased systemic blood pressure, and marked cardiac interstitial fibrosis
Platforms like MeAgain bring together shot logs, protein and water intake tracking, injection-site records, and side-effect timelines
A 2023 Phase 2 clinical study on retatrutide published in the New England Journal of Medicine demonstrated significant reductions in body weight in research participants, underscoring its importance as a research compound
Mechanisms of benefit may include both weight reduction and direct pharmacological effects, such as reduced cerebrospinal fluid secretion via GLP-1 receptors in the choroid plexus, and anti-inflammatory/neuroprotective actions in the brain
You burp
doi: 10.1016/j.phymed.2021.153894 45 ZongYLiHLiaoPChenLPanYZhengYet al